• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Analysis of population immunity of residents of Russian Federation regions against seasonal and highly pathogenic strains of influenza virus

tetano

Editor, Senior Moderator
Zh Mikrobiol Epidemiol Immunobiol. 2014 Nov-Dec;(6):120-3.
[h=1][Analysis of population immunity of residents of Russian Federation regions against seasonal and highly pathogenic strains of influenza virus].[/h] [Article in Russian]
[No authors listed]
[h=3]Abstract[/h] [h=4]AIM:[/h] Determine the level of antibodies against socially significant types/serotypes of influenza virus in sera of individuals residing in various regions of Russia.
[h=4]MATERIALS AND METHODS:[/h] 1525 samples of blood sera collected in August-December 2013 in 8 regions of Russian Federation were studied in hemagglutination inhibition reaction (HAI) with antigens obtained from A/California/07/09, (H1N1)pdm09, A/Victoria/361/2011(H3N2), B/Brisbane/60/2008 (Victoria line), B/Massachusetts/2/2012 (Yamagata line), A/Commongull/Chany/2006 (H5N1), A/Anhui/01/2013 (H7N9) influenza virus strains.
[h=4]RESULTS:[/h] None of the blood sera samples had significant HAI titers against A/H5 and A/H7 antigens. Of all the 1525 samples, 788 (52%) were positive with A(H1N1)pdm09 antigen; 734 (48%) reacted with A(H3N2) antigen; 1010 (66%) samples were positive with B/Victoria antigen and 602 (39%) samples were positive with B/Yamagata antigen.
[h=4]CONCLUSION:[/h] Healthcare institutions should pay attention to the correction of population immunity profile in regions for the reduction of social-economic losses from seasonal influenza epidemics.


PMID: 25816528 [PubMed - in process]
 
Back
Top Bottom